A Model System for Robust Identification of Neoantigen-Specific T-cell Receptors ASPIRE AWARD (2018-2020; 2020-PRESENT) Michelle Krogsgaard, PhD (Principal); Jef Boeke, PhD; and Jeffrey Weber, MD, PhD, New York University Read More
Tumor-Specific Immunotherapy for a Rare Pediatric Liver Cancer ASPIRE Award (2020-Present) Paul Thomas, PhD, St. Jude Children’s Research Hospital Read More
Convergence of Machine Learning and Translational Genomics for Prostate Cancer Precision Medicine 2020 Emerging Leader Award - Arnold J. Levine Fellow Eliezer Van Allen, MD, Dana-Farber Cancer Institute Read More
Drug Combinations to Preempt Resistance in AML 2020 Emerging Leader Award Jeffrey Tyner, PhD, Oregon Health and Science University Read More
Targeting Cellular States and Plasticity in Glioblastoma 2020 Emerging Leader Award Mario Suvà, MD, PhD, Massachusetts General Hospital Read More
Exploiting Lymphatic Transport for Early Detection 2020 Emerging Leader Award Amanda Lund, PhD, New York University Read More
Mechanism of cGAS-STING Inactivation in Antitumor Immunity and Disease 2020 Emerging Leader Award Philip Kranzusch, PhD, Dana-Farber Cancer Institute Read More
Improving Cancer Immunotherapy through Metabolic Modulation 2020 Emerging Leader Award Greg Delgoffe, PhD, The University of Pittsburgh Read More
Long-Range Tumor-Host Signaling Mechanisms Driving Paraneoplastic Syndromes Damon Runyon - Mark Foundation Postdoctoral Fellow (2020-Present) Katy Ong, PhD, University of California, Berkeley Read More
Generating a Long-term Immune Response to Merkel Cell Carcinoma ASPIRE Award (2020-Present) Paul Nghiem, MD, PhD, University of Washington Read More
